Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Neoplasms and TRG[original query] |
|---|
| Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region. International journal of radiation oncology, biology, physics 2006 Oct 66 (2): 500-4. Spindler Karen-Lise Garm, Nielsen Jens Nederby, Lindebjerg Jan, Brandslund Ivan, Jakobsen Ande |
| A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation. Pharmacogenetics and genomics 2006 Nov 16 (11): 817-24. Terrazzino Salvatore, Agostini Marco, Pucciarelli Salvatore, Pasetto Lara Maria, Friso Maria Luisa, Ambrosi Alessandro, Lisi Veronica, Leon Alberta, Lise Mario, Nitti Dona |
| Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009 Mar 20 (3): 469-74. Bengala C, Bettelli S, Bertolini F, Salvi S, Chiara S, Sonaglio C, Losi L, Bigiani N, Sartori G, Dealis C, Malavasi N, D'Amico R, Luppi G, Gatteschi B, Maiorana A, Conte P |
| Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. British journal of cancer 2010 Sep 103 (7): 1019-24. Bengala C, Bettelli S, Bertolini F, Sartori G, Fontana A, Malavasi N, Depenni R, Zironi S, Del Giovane C, Luppi G, Conte P |
| Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy. The pharmacogenomics journal 2011 Jun 11 (3): 214-26. Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V, Sigon R, De Mattia E, Friso M L, Biason P, Visentin M, Nitti D, Toffoli |
| X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients. International journal of radiation oncology, biology, physics 2012 Jan 82 (1): 138-44. Lamas Maria J, Duran Goretti, Gomez Antonio, Balboa Emilia, Anido Urbano, Bernardez Beatriz, Rana-Diez Pablo, Lopez Rafael, Carracedo Angel, Barros Francis |
| Novel single-nucleotide polymorphism markers predictive of pathologic response to preoperative chemoradiation therapy in rectal cancer patients. International journal of radiation oncology, biology, physics 2013 Mar . Kim JC, Ha YJ, Roh SA, Cho DH, Choi EY, Kim TW, Kim JH, Kang TW, Kim SY, Kim YS |
| The role of plasma cell-free DNA detection in predicting preoperative chemoradiotherapy response in rectal cancer patients. Oncology reports 2014 Mar 31 (3): 1466-72. Sun W, Sun Y, Zhu M, Wang Z, Zhang H, Xin Y, Jiang G, Guo X, Zhang Z, Liu |
| Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases. Medical oncology (Northwood, London, England) 2015 Jul 32 (7): 182. Pietrantonio Filippo, Mazzaferro Vincenzo, Miceli Rosalba, Cotsoglou Christian, Melotti Flavia, Fanetti Giuseppe, Perrone Federica, Biondani Pamela, Muscarà Cecilia, Di Bartolomeo Maria, Coppa Jorgelina, Maggi Claudia, Milione Massimo, Tamborini Elena, de Braud Filip |
| Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer? Oncotarget 2016 May . Xiao Lin, Yu Xin, Zhang Rong, Chang Hui, Xi Shaoyan, Xiao Weiwei, Zeng Zhifan, Zhang Huizhong, Xu Ruihua, Gao Yuanho |
| Prognostic and Therapeutic Potential Implications of Genetic Variability in Prostaglandin E2 Pathway Genes in Rectal Cancer. Anticancer research 2017 Jan 37 (1): 281-291. Santos Marisa D, Silva Cristina, Rocha Anabela, Nogueira Carlos, Castro-Poças Fernando, Araujo António, Matos Eduarda, Pereira Carina, Medeiros Rui, Lopes Carl |
| Predictive clinical model of tumor response after chemoradiation in rectal cancer. Oncotarget 2017 Aug 8 (35): 58133-58151. Santos Marisa D, Silva Cristina, Rocha Anabela, Nogueira Carlos, Castro-Poças Fernando, Araujo António, Matos Eduarda, Pereira Carina, Medeiros Rui, Lopes Carl |
| Tumor regression grades, K-RAS mutational profile and c-MET in colorectal liver metastases. Pathology, research and practice 2017 Apr . Lorenzon Laura, Ricca Luana, Pilozzi Emanuela, Lemoine Antoinette, Riggio Valentina, Giudice Maria Teresa, Mallel Giuseppe, Fochetti Flavio, Balducci Genovef |
| KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis. International journal of colorectal disease 2021 3 36 (8): 1781-1790. Peng Junfu, Lv Jun, Peng Jishe |
| Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians. BMC cancer 2022 3 22 (1): 273. Wang Jun, Zhuge Jinke, Feng Dongxu, Zhang Bo, Xu Jianying, Zhao Dongkang, Fei Zhewei, Huang Xia, Shi Wenj |
| Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection. Radiation oncology journal 2022 1 39 (4): 304-314. Reddy Abhinav V, Hill Colin S, Sehgal Shuchi, Ding Ding, Hacker-Prietz Amy, He Jin, Zheng Lei, Herman Joseph M, Meyer Jeffrey, Narang Amol |
| SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy. Frontiers in pharmacology 2022 1 12 778781. De Mattia Elena, Canzonieri Vincenzo, Polesel Jerry, Mezzalira Silvia, Dalle Fratte Chiara, Dreussi Eva, Roncato Rossana, Bignucolo Alessia, Innocente Roberto, Belluco Claudio, Pucciarelli Salvatore, De Paoli Antonino, Palazzari Elisa, Toffoli Giuseppe, Cecchin Eri |
| Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response. Cancer medicine 2023 6 . Tae Hoon Lee, Bum-Sup Jang, Ji Hyun Chang, Eunji Kim, Jeong Hwan Park, Eui Kyu Ch |
| High risk of lung cancer in surfactant-related gene variant carriers. The European respiratory journal 2024 4 . Alexandre Brudon, Marie Legendre, Arthur Mageau, Julien Bermudez, Philippe Bonniaud, Diane Bouvry, Jacques Cadranel, Aurélie Cazes, Bruno Crestani, Tristan Dégot, Céline Delestrain, Rémi Diesler, Ralph Epaud, Quentin Philippot, Nathalie Theou-Anton, Caroline Kannengiesser, Ibrahima Ba, Marie-Pierre Debray, Pascale Fanen, Efrosine Manali, Spyros Papiris, Nadia Nathan, Serge Amselem, Antoine Gondouin, Anne Guillaumot, Claire Andréjak, Stephane Jouneau, Guillaume Beltramo, Yurdagul Uzunhan, François Galodé, Virginie Westeel, Anas Mehdaoui, Sandrine Hirschi, Sylvie Leroy, Sylvain Marchand-Adam, Hilario Nunes, Clément Picard, Grégoire Prevot, Martine Reynaud-Gaubert, Paul De Vuyst, Lidwine Wemeau, Gautier Defossez, Gérard Zalcman, Vincent Cottin, Raphael Borie, |
| The causal associations of circulating lipids with Barrett's Esophagus and Esophageal Cancer: a bi-directional, two sample mendelian randomization analysis. Human genomics 2024 4 18 (1): 37. Baofeng Li, Meng Li, Xiao Qi, Ti Tong, Guangxin Zha |
- Page last reviewed:Feb 1, 2024
- Content source: